OpenAlex
PricingAboutJobs
Log inGet started
Work

Enhanced Apoptosis and Tumor Growth Suppression Elicited by Combination of MEK (Selumetinib) and mTOR Kinase Inhibitors (AZD8055)

HTML

Year: 2012
Type: article
Source: Cancer Research
DOI: 10.1158/0008-5472.can-11-1780
Authors: Sarah V. Holt, Armelle Logie, Barry R. Davies, Denis Alferez, Sarah Runswick, Sarah Fenton, Christine M. Chresta, Yi Gu, Jingchuan Zhang, Yi-Long Wu, Robert W. Wilkinson, Sylvie M. Guichard, Paul D. Smith
Institutions: Guangdong General Hospital, Cancer Research UK Manchester Institute, Guangdong Academy of Medical Sciences
Language: English

Topic: PI3K/AKT/mTOR signaling in cancer
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: selumetinib, AZD8055, MEK inhibitors, mTOR inhibitors, combination therapy, MAPK signaling, PI3K/Akt signaling, apoptosis, building information modeling, DUSP6, lung adenocarcinoma, colorectal cancer, tumor growth inhibition
SDG: Good health and well-being

Open Access status: closed

Funder: AstraZeneca
OpenAlex ID: W2110528825
FWCI: 4.146
Cites: 54
Cited by: 91
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security